The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery
Open accessAbstract
Low penetration ability of Small Interfering RNA (siRNA) through the cellular plasma membrane combined with its limited stability in blood, limits the effectiveness of the systemic delivery of siRNA. In order to overcome such difficulties, we constructed a nanocarrier-based delivery system by taking advantage of the lessons learned from the problems in the delivery of DNA. In the present study, siRNA nanoparticles were first formulated with Poly(Propyleneimine) (PPI) dendrimers. To provide lateral and steric stability to withstand the aggressive environment in the blood stream, the formed siRNA nanoparticles were caged with a dithiol containing cross-linker molecules followed by coating them with Poly(Ethylene Glycol) (PEG) polymer. A synthetic analog of Luteinizing Hormone-Releasing Hormone (LHRH) peptide was conjugated to the distal end of PEG polymer to direct the siRNA nanoparticles specifically to the cancer cells. Our results demonstrated that this layer-by-layer modification and targeting approach confers the siRNA nanoparticles stability in plasma and intracellular bioavailability, provides for their specific uptake by tumor cells, accumulation of siRNA in the cytoplasm of cancer cells, and efficient gene silencing. In addition, in vivo body distribution data confirmed high specificity of the proposed targeting delivery approach which created the basis for the prevention of adverse side effects of the treatment on healthy organs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Kam, N. W. S., Liu, Z., & Dai, H. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053962k · Cited by 784
An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines
Snyder, S. L., & Sobocinski, P. Z. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90431-5 · Cited by 756
Development and characterisation of chitosan nanoparticles for siRNA delivery
Katas, H., & Alpar, H. O. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.021 · Cited by 642
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms
Bessis, N., GarciaCozar, F. J., & Boissier, M.-C. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302364 · Cited by 633
Miyata, K., Kakizawa, Y., Nishiyama, N., Harada, A., Yamasaki, Y., Koyama, H., & Kataoka, K. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0379666 · Cited by 394
Dash, P. R., Read, M. L., Barrett, L. B., Wolfert, M. A., & Seymour, L. W. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300843 · Cited by 386
Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells
Chiu, Y.-L., Ali, A., Chu, C.-Y., Cao, H., & Rana, T. M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.06.006 · Cited by 381
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Self-citationSpagnou, S., Miller, A. D., & Keller, M. (2004) · Biochemistry · doi:10.1021/bi048950a · Cited by 342
Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide
Dharap, S. S., Wang, Y., Chandna, P., Khandare, J. J., Qiu, B., Gunaseelan, S., Sinko, P. J., Stein, S., Farmanfarmaian, A., & Minko, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504274102 · Cited by 340
Self-citationOh, J. K., Tang, C., Gao, H., Tsarevsky, N. V., & Matyjaszewski, K. (2006) · Journal of the American Chemical Society · doi:10.1021/ja060586a · Cited by 333
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy
Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.023 · Cited by 273
Saad, M., Garbuzenko, O. B., Ber, E., Chandna, P., Khandare, J. J., Pozharov, V. P., & Minko, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.024 · Cited by 238
Self-citationKleemann, E., Neu, M., Jekel, N., Fink, L., Schmehl, T., Gessler, T., Seeger, W., & Kissel, T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.036 · Cited by 226
Patil, M. L., Zhang, M., Taratula, O., Garbuzenko, O. B., He, H., & Minko, T. (2009) · Biomacromolecules · doi:10.1021/bm8009973 · Cited by 213
Self-citationSurface-Modified and Internally Cationic Polyamidoamine Dendrimers for Efficient siRNA Delivery
Patil, M. L., Zhang, M., Betigeri, S., Taratula, O., He, H., & Minko, T. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8000722 · Cited by 213
Self-citationMonomolecular collapse of plasmid DNA into stable virus-like particles
Blessing, T., Remy, J.-S., & Behr, J.-P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1427 · Cited by 204
Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides
Dharap, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00209-8 · Cited by 172
Garbuzenko, O. B., Saad, M., Betigeri, S., Zhang, M., Vetcher, A. A., Soldatenkov, V. A., Reimer, D. C., Pozharov, V. P., & Minko, T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9755-4 · Cited by 167
Self-citationEfficient siRNA Delivery with Non-viral Polymeric Vehicles
Kim, W. J., & Kim, S. W. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9774-1 · Cited by 166
Oupický, D., Carlisle, R. C., & Seymour, L. W. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301446 · Cited by 151
Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier
Kim, T., Baek, J.-U., Bai, C. Z., & Park, J. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.013 · Cited by 150
Pakunlu, R. I., Wang, Y., Tsao, W., Pozharov, V. P., Cook, T. J., & Minko, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0001 · Cited by 148
Self-citationOoya, T., Lee, J., & Park, K. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049814l · Cited by 140
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes
van Steenis, J. H., van Maarseveen, E. M., Verbaan, F. J., Verrijk, R., Crommelin, D. J. A., Storm, G., & Hennink, W. E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00361-9 · Cited by 118
Caged DNA Does Not Aggregate in High Ionic Strength Solutions
Trubetskoy, V. S., Loomis, A., Slattum, P. M., Hagstrom, J. E., Budker, V. G., & Wolff, J. A. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9801530 · Cited by 85
Novel Polymeric Prodrug with Multivalent Components for Cancer Therapy
Khandare, J. J., Chandna, P., Wang, Y., Pozharov, V. P., & Minko, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098855 · Cited by 83
Self-citationShim, M. S., & Kwon, Y. J. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.007 · Cited by 77
Targeted Proapoptotic Anticancer Drug Delivery System
Chandna, P., Saad, M., Wang, Y., Ber, E., Khandare, J. J., Vetcher, A. A., Soldatenkov, V. A., & Minko, T. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070053o · Cited by 69
Self-citationIncorporation of Reversibly Cross-Linked Polyplexes into LPDII Vectors for Gene Delivery
Gosselin, M. A., Guo, W., & Lee, R. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025512c · Cited by 54
Chen, A. M., Santhakumaran, L. M., Nair, S. K., Amenta, P. S., Thomas, T., He, H., & Thomas, T. (2006) · Nanotechnology · doi:10.1088/0957-4484/17/21/027 · Cited by 29
Self-citation
Cited by
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Palmerston Mendes, L., Pan, J., & Torchilin, V. (2017) · Molecules · doi:10.3390/molecules22091401 · Cited by 701
Biomedical applications of dendrimers: a tutorial
Mintzer, M. A., & Grinstaff, M. W. (2011) · Chem. Soc. Rev. · doi:10.1039/b901839p · Cited by 671
Metadata
- Authors
- Taratula, O., Garbuzenko, O. B., Kirkpatrick, P., Pandya, I., Savla, R., Pozharov, V. P., He, H., & Minko, T.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 140
- Issue
- 3
- Pages
- 284-293
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1982464351
- Cited by
- 328
- References
- 34
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.